Skip to main content
Fig. 3 | Child and Adolescent Psychiatry and Mental Health

Fig. 3

From: Short-term cognitive effects of repeated-dose esketamine in adolescents with major depressive disorder and suicidal ideation: a randomized controlled trial

Fig. 3

Overall changes in cognitive performance between groups at Days 0, 6, and 12, with significant differences in processing speed between groups at Days 6 and 12. A A significant increase in the score of processing speed in esketamine group from baseline to Days 6 and 12. B A significant increase in the score of working memory in esketamine group from baseline to Day 12. C No significant change of verbal learning in either group from baseline to Day 6 or 12. D No significant change of visual learning in either group from baseline to Day 6 or 12. Asterisk (*) represents significant difference between groups (*P < 0.05)

Back to article page

Child and Adolescent Psychiatry and Mental Health

ISSN: 1753-2000